This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Albert Einstein College of Medicine, University of Manitoba. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 514 
2 out of 212 
Years Active: 2023-2026
Title: Richard N Kitsis: Innovator in Cardiovascular Research
Introduction
Richard N Kitsis is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cardiovascular research, holding 3 patents that focus on innovative treatments for diseases and disorders.
Latest Patents
Kitsis's latest patents include "Small molecule BAX inhibitors and uses thereof," which discloses compounds, compositions, and methods for treating diseases where inhibiting BAX is desirable, such as cardiovascular diseases. Another notable patent is "Mitofusin activators and uses thereof," which details activators of mitofusins and their applications in treating various diseases and disorders.
Career Highlights
Throughout his career, Richard N Kitsis has worked with esteemed institutions, including the Albert Einstein College of Medicine and the University of Manitoba. His research has significantly advanced the understanding of cardiovascular health and potential therapeutic interventions.
Collaborations
Kitsis has collaborated with notable colleagues, including Evripidis Gavathiotis and Dulguun Amgalan, contributing to a rich exchange of ideas and research advancements in his field.
Conclusion
Richard N Kitsis stands out as an influential inventor in cardiovascular research, with a focus on innovative treatments that have the potential to improve patient outcomes. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile